Table 2.1.
OR of the direct evidence |
|||
Placebo | Granisetron | Ondansetron | |
Median OR from the MTC | |||
Placebo | – | OR 3.13 (1.16 to 8.49)** | OR 3.88 (2.6 to 5.77)*** |
Granisetron | 3.25 (0.62 to 17.69) | – | No data available |
Ondansetron | 4.33 (2.11 to 10.11)*** | 1.33 (0.21 to 8.76) | – |
**p<0.05; ***p<0.01.
Estimated best treatment option: ondansetron 65%, granisetron 35% and placebo 0%.